“Opening a New Front in the War Against Cancer”
A Presentation by Dr. Craig Dees, Ph.D., Chairman and CEO of Provectus Pharmaceuticals
Wednesday, March 31, 2010: 6 pm – 9 pm
Complimentary Cocktails: 6 pm – 7pm
Presentation: 7 pm
Members and Non-members welcome!
This is a complimentary event
Seating is limited so please RSVP to this address by March 25, 2010
Please forward this to interested colleagues and associates!
Please join us at Panevino Ristorante for an insightful presentation on fighting cancer by Craig Dees, Chairman and CEO of Provectus Pharmaceuticals, followed by a lively Q&A session.
Provectus is a development stage company specializing in oncology and dermatology therapies that are safer, more effective, less invasive and more economical than conventional therapies. Provectus is conducting Phase 2 clinical trials of its proprietary drugs PV-10, as a therapy for metastatic melanoma, and PH-10, as a topical treatment for psoriasis and atopic dermatitis.
Craig Dees has spent more than 20 years in senior management positions at Photogen Technologies, the Oak Ridge National Laboratory, LipoGen, and TechAmerica. He was a founder, senior scientist and founding director of Photogen before Provectus was formed. Craig’s responsibilities have included product design and development in ethical vaccines, cosmetics, human diagnostics, and over-the-counter pharmaceuticals. His development record includes the first live viral vaccine produced by recombinant DNA technologies and the first recombinant antigen human diagnostic assay. Craig has also successfully licensed a number of proprietary cosmetic products. In addition to design and development activities, he has been responsible for business and market applications, regulatory affairs, and commercialization of human and veterinary medical products. Craig’s awards include an R&D 100 for an industrial enzyme, an Inventor’s Forum New Product Award for a skincare product, and a First Saber Award for outstanding research in virology. He holds a Ph.D. in molecular virology from University of Wisconsin, Madison, a Master of Science degree in immunology from Auburn University, and a Bachelor’s degree in microbiology from Brigham Young University.